drugset / Trial / NCT00265369

TEDDY: Spores of Bacillus Clausii in Acute Diarrhoea in Children

NCT00265369 ↗

Phase 3 Completed 420 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

Primary objective: * To demonstrate the efficacy of a Bacillus clausii probiotic strain compared to placebo in children suffering from acute diarrhoea and treated for 7 days. Secondary objective: * To evaluate the clinical safety of the Bacillus clausii probiotic strain versus placebo.

Timeline

Start
2004-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacillus Clausii Probiotic Strain Unknown — —

Indications